Clinical trial
Iloprost Therapy in Patients With Critical Limb Ischemia: Evaluation of Efficacy and Safety
NCT01458041 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Iloprost Therapy in Patients With Critical Limb Ischemia: Evaluation of Efficacy and Safety
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2011
- Completion date
- December 31, 2014
- Enrollment
- 126 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.